Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Flutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 47 Polycystic Ovary Syndrome 6 Infertility 2 Hyperandrogenism 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Prostatic Intraepithelial Neoplasia 1 Prostate Adenocarcinoma 1 Primary Dysautonomias 1 Overweight 1 Ovarian Neoplasms 1 Oligomenorrhea 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Kidney Diseases 1 Insulin Resistance 1 Hypertension 1 Hirsutism 1 Castration-resistant Prostate Cancer 1 Carcinoma, Ovarian Epithelial 1 Anovulation 1 Amenorrhea 1 Adenocarcinoma 1

Interventions

pembrolizumab 155 Gemcitabine 140 Capecitabine 123 Paclitaxel 120 Fluorouracil 117 Oxaliplatin 110 Bevacizumab 106 Nivolumab 98 Leucovorin 97 Docetaxel 97 Cisplatin 89 Radiosurgery 88 Irinotecan 87 Carboplatin 85 Cetuximab 72 Cyclophosphamide 71 Magnetic Resonance Spectroscopy 67 Radiotherapy 60 Trastuzumab 59 Biopsy 59 Specimen Handling 58 Ipilimumab 51 Drug Therapy 51 Everolimus 48 Pemetrexed 45 Albumin-Bound Paclitaxel 45 130-nm albumin-bound paclitaxel 44 Doxorubicin 42 Fulvestrant 39 aldesleukin 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡